874302-76-8

Basic information

• Product Name: 4-nitrophenyl 2-(2-(pyridin-2-yl)disulfanyl)ethyl carbonate
• Synonyms: 4-nitrophenyl 2-(2-(pyridin-2-yl)disulfanyl)ethyl carbonate
• CAS NO: 874302-76-8
• Molecular Weight: 352.392
• Mol File: 874302-76-8.mol
• Article Data: 32

Chemical Properties

• Boiling Point: 527.7±50.0 °C(Predicted)
• Density: 1.46±0.1 g/cm3(Predicted)
• CAS DataBase Reference: 4-nitrophenyl 2-(2-(pyridin-2-yl)disulfanyl)ethyl carbonate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-nitrophenyl 2-(2-(pyridin-2-yl)disulfanyl)ethyl carbonate(874302-76-8)
• EPA Substance Registry System: 4-nitrophenyl 2-(2-(pyridin-2-yl)disulfanyl)ethyl carbonate(874302-76-8)

Safety Data

• Hazardous Substances Data: 874302-76-8(Hazardous Substances Data)

Usage

General Description

4-nitrophenyl 2-(2-(pyridin-2-yl)disulfanyl)ethyl carbonate is a chemical compound with the molecular formula C18H15N2O6S2. It is a carbonate ester consisting of a 4-nitrophenyl group, a disulfide bond, and a pyridine ring. 4-nitrophenyl 2-(2-(pyridin-2-yl)disulfanyl)ethyl carbonate is often used as a reagent in organic synthesis, particularly in the formation of disulfide bonds in peptides and proteins. It is also known for its potential application in the development of pharmaceuticals and organic materials. Additionally, it may have uses in the study of redox reactions and in the preparation of functionalized polymers. The compound's unique structure and properties make it valuable in a variety of chemical and biological research applications.

Upstream product

• 7693-46-1 4-Nitrophenyl chloroformate 
• 5070-13-3 bis-(p-nitrophenyl) carbonate 
• 111625-28-6 2-(2-(Pyridin-2-yl)disulfanyl)ethanol 
• 2637-34-5 2-Sulfanylpyridine 
• 2127-03-9 2,2'-dipyridyldisulphide 

Downstream Products

• 1369516-09-5 2'-(2-(2-(pyridin-2-yl)disulfanyl)ethylcarbonate)docetaxel 
• 1032313-88-4 C₅₅H₅₈N₂O₁₆S₂ 

Relevant articles and documents

Multifunctionalization of magnetic nanoparticles for controlled drug release: A general approach

In this study, a general approach for the multifunctionalization of magnetic nanoparticles (MNPs) with drugs (Doxorubicin and Gemcitabine) and targeting moieties (Nucant pseudopeptide) for controlled and selective release is described. The functionalizati

GLP1R AGONIST NMDAR ANTAGONIST CONJUGATES

The present invention relates to a conjugated molecule comprising a peptide displaying at least 0.1% activity of native glucagon-like peptide 1 (GLP-1) at the GLP-1 receptor, and an N-methyl-D-aspartate receptor (NMDAR) antagonist, the peptide being coval

ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME

The present invention provides drug modifications for improving biodistribution and/or specificity of an anticancer drug. In certain embodiments, the compound of the invention comprises a drug, a linker and a core acid. The core acid can be varied to tune

POLYMERIC CONJUGATES AND USES THEREOF

The present invention relates to novel chemical entities comprising a polymeric carrier incorporating covalently linked drug(s) as well as their pharmaceutical compositions containing the said polymer-drug conjugates as pharmaceutical agents and their use